Avecho Biotechnology Balance Sheet Health
Financial Health criteria checks 6/6
Avecho Biotechnology has a total shareholder equity of A$4.2M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$5.9M and A$1.6M respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
| Interest coverage ratio | n/a |
| Cash | AU$4.84m |
| Equity | AU$4.22m |
| Total liabilities | AU$1.65m |
| Total assets | AU$5.86m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AVEF.F's short term assets (A$5.6M) exceed its short term liabilities (A$1.6M).
Long Term Liabilities: AVEF.F's short term assets (A$5.6M) exceed its long term liabilities (A$58.8K).
Debt to Equity History and Analysis
Debt Level: AVEF.F is debt free.
Reducing Debt: AVEF.F has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AVEF.F has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: AVEF.F has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 15.4% each year.